Siemens offers the industry’s largest nephelometric menu of plasma protein assays, including innovative assays such as Free Light Chains (FLC) for myeloma, Carbohydrate-deficient Transferrin (CDT) for the detection of chronic alcohol abuse, and Beta-Trace Protein (BTP) for cerebrospinal fluid (CSF) leakage and residual renal function (RRF).